Esomeprazole 40mg + Itopride 150mg Capsule in pharma franchise in Lucknow

Esomeprazole 40mg + Itopride 150mg Capsule in PCD pharma franchise in Jaipur

Esomeprazole 40mg + Itopride 150mg Capsule in top pharma company in Mumbai

Esomeprazole 40mg + Itopride 150mg Capsule in PCD pharma supplier in Noida

Esomeprazole 40mg + Itopride 150mg Capsule in pharma franchise company in India
Esomeprazole 40mg + Itopride 150mg Capsule in pharma distributor in Delhi

Home/Products /esomeprazole-40-mg-itopride-150-mg-capsule

About the Product

Description


Esoable IT Capsule is a dual-action gastro-prokinetic and acid suppressant formulation containing Esomeprazole 40 mg, a proton pump inhibitor (PPI), and Itopride 150 mg, a prokinetic agent. This combination is effective in managing gastroesophageal reflux disease (GERD), functional dyspepsia, and acid-related disorders. Esomeprazole reduces gastric acid secretion to provide lasting relief from acidity and ulcers, while Itopride enhances gastrointestinal motility, relieving bloating, nausea, and gastric stasis.

Used in the treatment of GERD, acid reflux, non-ulcer dyspepsia, and related gastric motility disorders.

May include headache, diarrhea, abdominal pain, or dizziness. Long-term use should be monitored due to risks of nutrient malabsorption.

Should be taken before meals as directed by the physician. Use with caution in patients with liver impairment or history of GI bleeding.

Store in a cool, dry place away from direct sunlight. Keep out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Esoable IT Capsule in the PCD pharma franchise market?

Esoable IT Capsule, containing Esomeprazole 40mg and Itopride 150mg, has strong demand in the gastroenterology and digestive care segment, making it a profitable product for medical distributors, wholesalers, and pharma franchise partners looking to expand their gastrointestinal care portfolio.

Why should medical distributors include Esoable IT Capsule in their product range?

Medical distributors and agencies can benefit from the increasing market demand for medicines used in acidity, GERD, indigestion, bloating, and gastric discomfort management. Esoable IT Capsule helps strengthen a comprehensive gastro care product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for Esoable IT Capsule?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Esoable IT Capsule with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for Esoable IT Capsule distribution?

Wholesalers and medical agencies benefit from attractive business margins, reliable product availability, professional support, and access to a trusted gastrointestinal care product range when partnering for Esoable IT Capsule distribution.

How can I become a distributor or franchise partner for Esoable IT Capsule?

Medical distributors, stockists, and wholesalers interested in Esoable IT Capsule can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.